THE POTENTIAL LONG-TERM COMPARATIVE EFFECTIVENESS OF LAROTRECTINIB VS. LENVATINIB OR SORAFENIB FOR TREATMENT OF NTRK FUSION-POSITIVE METASTATIC THYROID CANCER

被引:0
|
作者
Carlson, J. [1 ]
Suh, K. [2 ]
Xia, F. [3 ]
Williamson, T. [3 ]
Sullivan, S. [4 ]
机构
[1] Univ Washington, Seattle, WA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Bayer US LLC, Whippany, NJ USA
[4] Univ Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN11
引用
收藏
页码:S20 / S20
页数:1
相关论文
共 50 条
  • [31] Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
    Yoon Young Cho
    Soo Kyoung Kim
    Jung Hwa Jung
    Jong Ryeal Hahm
    Tae Hyuk Kim
    Jae Hoon Chung
    Sun Wook Kim
    Endocrine, 2019, 64 : 293 - 298
  • [32] Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
    Cho, Yoon Young
    Kim, Soo Kyoung
    Jung, Jung Hwa
    Hahm, Jong Ryeal
    Kim, Tae Hyuk
    Chung, Jae Hoon
    Kim, Sun Wook
    ENDOCRINE, 2019, 64 (02) : 293 - 298
  • [33] Operative vs. nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results.
    Habr-Gama, A
    Perez, RO
    Bocchini, SF
    Kiss, DR
    Nahas, SC
    Coser, R
    Gama-Rodrigues, J
    DISEASES OF THE COLON & RECTUM, 2004, 47 (06) : 1005 - 1006
  • [34] Cardiotoxicity Related to Long-Term Trastuzumab Therapy in Metastatic Breast Cancer: The Potential Role of Treatment Duration and Cardiac Risk Factors
    Pistilli, Barbara
    Marcellusi, Andrea
    Latini, Luciano
    Accardi, Roberto
    Ferretti, Benedetta
    Benedetti, Giovanni
    BREAST JOURNAL, 2015, 21 (03): : 318 - 321
  • [35] Comparative long-term oncological outcomes of intraoperative radiotherapy vs. whole-breast irradiation in early breast cancer: a single institute study
    Chi, Mau-Shin
    Ko, Hui-Ling
    Yang, Tsen-Long
    Liu, Ya-Fang
    Chi, Kwan-Hwa
    Cheng, Fiona Tsui-Fen
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [36] Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
    Montemurro, F.
    Prat, A.
    Rossi, V.
    Valabrega, G.
    Sperinde, J.
    Peraldo-Neia, C.
    Donadio, M.
    Galvan, P.
    Sapino, A.
    Aglietta, M.
    Baseiga, J.
    Scaltriti, M.
    CANCER RESEARCH, 2013, 73
  • [37] Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
    Montemurro, Filippo
    Prat, Aleix
    Rossi, Valentina
    Valabrega, Giorgio
    Sperinde, Jeff
    Peraldo-Neia, Caterina
    Donadio, Michela
    Galvan, Patricia
    Sapino, Anna
    Aglietta, Massimo
    Baselga, Jose
    Scaltriti, Maurizio
    MOLECULAR ONCOLOGY, 2014, 8 (01) : 20 - 26
  • [38] A comparative study of the TVT and IVS procedure for the treatment of stress urinary incontinence: Long-term follow-up of the monofilament vs. the multifilament polypropylene sling
    Prien-Larsen, J.
    Hemmingsen, L.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 : S4 - S5
  • [39] Efficacy and safety of infliximab in long-term treatment of plaque-type psoriasis: A comparative retrospective study on two different (continuous vs. relapse related) regimens
    Giunta, Alessandro
    Papoutsaki, Marina
    Bianchi, Luca
    Chimenti, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB190 - AB190
  • [40] Long-term remission of hormone receptor-positive/HER2-positive metastatic breast cancer due to combined treatment with everolimus/trastuzumab/exemestane: A case report
    Wang, Jian
    Sun, Chunxiao
    Huang, Xiang
    Qiu, Jinrong
    Yin, Yongmei
    ONCOLOGY LETTERS, 2017, 14 (02) : 1725 - 1730